Search Results - "RIEUX, C"

Delayed hemolytic transfusion reaction in the French hemovigilance system by Rieux, C., Brittenham, G., Bachir, D., De Meyer, E., Boudjedir, K.

“…In France, reporting of adverse events related, or likely to be related, to transfusion is mandatory. Since its creation in 1993, the French hemovigilance…”
Get full text

Delayed hemolytic transfusion reaction in sicle cell disease patients: a new challenge for the Hemovigilance network by Rieux, C, De Meyer, E, Boudjedir, K

“…Delayed hemolytic reaction transfusion in patients with sickle cell disease (SCD) is a serious and still under diagnosed event. Clinical and biological…”
Get more information

Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients by Thieblemont, C, Bastion, Y, Berger, F, Rieux, C, Salles, G, Dumontet, C, Felman, P, Coiffier, B

“…Characteristics and outcome of 108 patients with mucosa-associated lymphoid tissue (MALT) lymphoma were analyzed according to initial location of the lymphoma,…”
Get more information

Transfusion-associated circulatory overload by Ozier, Y, Mouquet, F, Rieux, C, Mertes, P-M, Muller, J-Y, Caldani, C, Boudjedir, K, Carlier, M

“…A working group of the French National Hemovigilance Committee has been in charge of heightening awareness of Transfusion-Associated Circulatory Overload…”
Get more information

Biological diagnosis of resistance to erlotinib in a malignant pleural effusion by Rieux, C, Boisdron-Celle, M, Morel, A, Fey, L, Urban, T, Hureaux, J

“…The characterization of genetic abnormalities in non-small cell lung cancer (NSCLC) constitutes a theranostic revolution which is leading to rapid progress in…”
Get more information

A UMLS-based knowledge acquisition tool for rule-based clinical decision support system development by Achour, S L, Dojat, M, Rieux, C, Bierling, P, Lepage, E

“…Decision support systems in the medical field have to be easily modified by medical experts themselves. The authors have designed a knowledge acquisition tool…”
Get full text

Analysis of Immunohistochemical Label of Fos Protein in the Suprachiasmatic Nucleus: Comparison of Different Methods of Quantification by Rieux, C., Carney, R., Lupi, D., Dkhissi-Benyahya, O., Jansen, K., Chounlamountri, N., Foster, R. G., Cooper, H. M.

“…The induction of the proto-oncogene c-fos, and its phosphoprotein product Fos, has been extensively used to study the effects of light on the circadian…”
Get full text

Disparities in particulate matter (PM10) origins and oxidative potential at a city scale (Grenoble, France) – Part 2: Sources of PM10 oxidative potential using multiple linear regression analysis and the predictive applicability of multilayer perceptron neural network analysis by Lucille Joanna S Borlaza, Weber, Samuël, Jaffrezo, Jean-Luc, Houdier, Stephan, Slama, Rémy, Rieux, Camille, Albinet, Alexandre, Micallef, Steve, Trébluchon, Cécile, Uzu, Gaëlle

“…The oxidative potential (OP) of particulate matter (PM) measures PM capability to potentially cause anti-oxidant imbalance. Due to the wide range and complex…”
Get full text

Successful cryopreservation of purified autologous CD34+ cells : influence of freezing parameters on cell recovery and engraftment by BEAUJEAN, F, BOURHIS, J.-H, BAYLE, C, JOUAULT, H, DIVINE, M, RIEUX, C, JANVIER, M, LE FORESTIER, C, PICO, J. L

“…Conventional hematopoietic stem cell cryopreservation methods use a DMSO concentration of 10%. However, cells manipulated ex vivo may require more refined…”
Get full text

Œdèmes aigus pulmonaires de surcharge post-transfusionnels by Ozier, Y., Mouquet, F., Rieux, C., Mertes, P.-M., Muller, J.-Y., Caldani, C., Boudjedir, K., Carlier, M.

“…La commission nationale d’hémovigilance a chargé un groupe de travail d’élaborer un document sur les œdèmes pulmonaires de surcharge post-transfusionnels…”
Get full text

1404P Clinical characteristics and therapeutics sequences of KRAS G12C metastatic non-small cell lung cancer (mNCSLC) patients treated by sotorasib in the French pre-marketing authorization (MA) early access program (cohort temporary authorization of use, cATU) by Lena, H., Cadranel, J., Girard, N., Mazieres, J., Curcio, H., Gille, R., Madroszyk Flandin, A-C., Auliac, J.B., Bylicki, O., Rieux, C., Couraud, S., Barlesi, F., Pichon, E., Métivier, A-C., Almotlak, H., Pabst, L., Deldycke, C., Duchemann, B., De Gunten, L., Quantin, X.

Get full text

Tandem autotransplant as first-line consolidative treatment in poor-risk aggressive lymphoma: A pilot study of 36 patients by Haioun, C., Mounier, N., Quesnel, B., Morel, P., Rieux, C., Beaujean, F., Marolleau, J.-P., Belhadj, K., Simon, D., Gaulard, Ph, Lepage, E., Gisselbrecht, Ch, Reyes, F.

“…Summary Purpose: In the previous LNH87-2 study, consolidative high-dose therapy followed by stem cell transplantation (HDT) improved disease-free survival, as…”
Get full text

High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation : a single-institution retrospective study of 69 BMTs by EL KASSAR, N, LEGOUVELLO, S, JOSEPH, C. M, SALESSES, P, RIEUX, C, CORDONNIER, C, VERNANT, J. P, FARCET, J. P, BIERLING, P, KUENTZ, M

“…The results of unrelated donor transplantation (URD-BMT) are difficult to analyze since the continuous advances in HLA typing technology allow the detection of…”
Get full text

1121P Real-world (RW) data from the sotorasib French pre-market authorization early access program in patients (pts) with KRASG12C driven metastatic non-small cell lung cancer (mNSCLC): Clinical characteristics by Cadranel, J., Quantin, X., Girard, N., Barlesi, F., Auliac, J.B., Couraud, S., Madroszyk Flandin, A-C., Pabst, L., Rieux, C., Curcio, H., Gille, R., Métivier, A-C., Becht, C., Bylicki, O., Tomasini, P., Veillon, R., Damade, C., Mourad, C., Veillard, C., Lena, H.

Get full text

LBA69 Impact of the COVID-19 pandemic on management of medical cancer treatments and psychological consequence for the patients by Joly, F., Leconte, A., Grellard, J-M., Lequesne, J., Binarelli, G., Lange, M., Tron, L., Gernier, F., Rieux, C., Fernette, M., Bastien, E., Morel, A., Legrand, B., Richard, D., Faveyrial, A., Travers, R., Pépin, L-F., Rigal, O., Jardin, F., Clarisse, B.

Get full text

Radiation-induced bone sarcoma following total body irradiation : role of additional radiation on localized areas by KIROVA, Y. M, RAFI, H, VOISIN, M.-C, RIEUX, C, KUENTZ, M, LE MOUEL, S, LEVY, E, CORDONNIER, C

“…A 44-year-old patient who had had acute monoblastic leukemia developed an osteosarcoma of the pelvic bones 5 years after an allogeneic bone marrow transplant…”
Get full text

Knowledge acquisition environment for the design of a decision support system: application in blood transfusion by Achour, S L, Dojat, M, Rieux, C, Bierling, P, Lepage, E

“…Blood transfusion is a medical domain where decision support systems (DSSs) could be very helpful to the physicians but must easily and continuously be…”
Get full text

POEMS syndrome, arterial thrombosis and thrombocythaemia by Zenone, T, Bastion, Y, Salles, G, Rieux, C, Morel, D, Felman, P, Espinouse, D, Bryon, P A, Coiffier, B

“…The case of a 22-year-old man with polyneuropathy, endocrinopathy, skin change and monoclonal gammopathy of IgG-lambda type is described. There was no solitary…”
Get more information

Fatigue and quality of life (QoL) during and after adjuvant treatment by trastuzumab (Herceptin®) among breast cancer patients (BC pts): a case-control study by Noal, S., Heutte, N., Allouache, D., Delcambre, C., Faveyrial, A., Levy, C., Segura, C., Geffrelot, J., Rieux, C., Leconte, A., Clarisse, B.

Get full text

Impact of art therapy (AT) on fatigue and quality of life (QoL) during adjuvant external beam irradiation (EBI) in breast cancer patients (pts): a randomized trial by Joly, F., Pasquier, D., Hanzen, C., Heutte, N., Levy, C., Le Tinier, F., Mousseau, M., Ciais, C., Murariu, C., D'almeida, M.-C., Szymczak, V., Leon, C., Darbas, S., Rousselot, M.-P., Mineur, S., Rieux, C., Leconte, A., Rigal, O., Clarisse, B., Allouache, D.

Get full text